Levbid Tablet, Extended Release
NDC Package 68220-115-10
Package Information
Levbid (hyoscyamine sulfate) tablets is hyoscyamine is used to treat a variety of stomach/intestinal problems such as cramps and irritable bowel syndrome. This formulation utilizes a tablet, extended release delivery system. Marketed by Viatris Specialty Llc, this product is identified by NDC 68220-115.
Identification & Billing
- RxCUI: 1046770 - hyoscyamine sulfate 0.375 MG 12HR Extended Release Oral Tablet
- RxCUI: 1046770 - 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet
- RxCUI: 1046770 - hyoscyamine sulfate 0.375 MG 12 HR Extended Release Oral Tablet
- RxCUI: 1046770 - hyoscyamine sulfate 375 MCG 12 HR Extended Release Oral Tablet
- RxCUI: 1046771 - Levbid 0.375 MG 12HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68220 - Viatris Specialty Llc
- 68220-115 - Levbid
- 68220-115-10 - 1 TABLET, EXTENDED RELEASE in 1 BOTTLE
- 68220-115 - Levbid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68220-115-10 identifies a specific commercial package of 1 tablet, extended release in 1 bottle of Levbid, a human prescription drug labeled by Viatris Specialty Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This tablet, extended release is formulated for oral use and contains hyoscyamine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Viatris Specialty Llc on December 01, 2008. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Hyoscyamine is used to treat a variety of stomach/intestinal problems such as cramps and irritable bowel syndrome. It is also used to treat other conditions such as bladder and bowel control problems, cramping pain caused by kidney stones and gallstones, and Parkinson's disease. In addition, it is used to decrease side effects of certain medications (drugs used to treat myasthenia gravis) and insecticides. This medication works by decreasing acid production in the stomach, slowing down the natural movements of the gut, and relaxing muscles in many organs (such as the stomach, intestines, bladder, kidney, gallbladder). Hyoscyamine also lessens the amount of certain body fluids (e.g., saliva, sweat). This medication belongs to a class of drugs known as anticholinergics/antispasmodics.
How is this Viatris Specialty Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68220011510. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.